Orthometrix, Inc.
OMRX · OTC
9/30/2008 | 6/30/2008 | 3/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | -42.5% | -37.8% | -50.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 9.7% | 30.1% | 47% | 46.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | -$0 | $0 |
| Operating Expenses | -$0 | -$0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | -$0 |
| % Margin | 184.6% | 79.4% | 41.6% | -2.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -238% | -117.3% | -66.3% | -19.4% |
| EPS | -0.01 | -0.01 | -0.01 | -0.003 |
| % Growth | 0% | 0% | -222.6% | – |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.003 |
| Weighted Avg Shares Out | 50 | 47 | 46 | 46 |
| Weighted Avg Shares Out Dil | 50 | 47 | 46 | 46 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -145.6% | -77.6% | -40.5% | 3.3% |